DE69220382D1 - Verwendung von Peptidderivaten - Google Patents

Verwendung von Peptidderivaten

Info

Publication number
DE69220382D1
DE69220382D1 DE69220382T DE69220382T DE69220382D1 DE 69220382 D1 DE69220382 D1 DE 69220382D1 DE 69220382 T DE69220382 T DE 69220382T DE 69220382 T DE69220382 T DE 69220382T DE 69220382 D1 DE69220382 D1 DE 69220382D1
Authority
DE
Germany
Prior art keywords
peptide derivatives
peptide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69220382T
Other languages
English (en)
Other versions
DE69220382T2 (de
Inventor
Hiroshi Kitaguchi
Hiroyuki Komazawa
Masayoshi Kojima
Hideto Mori
Naoyuki Nishikawa
Hideaki Satoh
Atsushi Orikasa
Mitsunori Ono
Ikuo Saiki
Ichiro Azuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Application granted granted Critical
Publication of DE69220382D1 publication Critical patent/DE69220382D1/de
Publication of DE69220382T2 publication Critical patent/DE69220382T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F289/00—Macromolecular compounds obtained by polymerising monomers on to macromolecular compounds not provided for in groups C08F251/00 - C08F287/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69220382T 1991-02-14 1992-02-13 Verwendung von Peptidderivaten Expired - Fee Related DE69220382T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4086091 1991-02-14
JP29748291 1991-11-13
JP4022799A JP2745351B2 (ja) 1991-02-14 1992-02-07 ペプチド誘導体及びその用途

Publications (2)

Publication Number Publication Date
DE69220382D1 true DE69220382D1 (de) 1997-07-17
DE69220382T2 DE69220382T2 (de) 1997-09-18

Family

ID=27283972

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69220382T Expired - Fee Related DE69220382T2 (de) 1991-02-14 1992-02-13 Verwendung von Peptidderivaten
DE69223266T Expired - Fee Related DE69223266T2 (de) 1991-02-14 1992-02-13 Peptidderivate und deren Verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69223266T Expired - Fee Related DE69223266T2 (de) 1991-02-14 1992-02-13 Peptidderivate und deren Verwendung

Country Status (4)

Country Link
US (1) US5436221A (de)
EP (2) EP0503301B1 (de)
JP (1) JP2745351B2 (de)
DE (2) DE69220382T2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0391928B1 (de) * 1987-09-28 1993-12-01 La Jolla Cancer Research Foundation Auswahl von zellen mit verbesserten zelladhäsionseigenschaften
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
CA2145847A1 (en) * 1992-10-02 1994-04-14 Richard T. Dean Multimeric polyvalent antithrombotic agents
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US6037324A (en) 1996-01-04 2000-03-14 Leukosite, Inc. Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
US5840514A (en) * 1996-11-21 1998-11-24 The Regents Of The University Of Michigan Methods of testing cancer and anticancer drugs
US6001965A (en) 1996-11-21 1999-12-14 The Regents Of The University Of Michigan Anticancer compounds and methods
AU2003271173A1 (en) * 2002-10-11 2004-05-04 Chugai Seiyaku Kabushiki Kaisha Cell growth regulator
JP4753022B2 (ja) * 2004-02-17 2011-08-17 独立行政法人産業技術総合研究所 プリオン増殖抑制剤
US20060078535A1 (en) * 2004-10-13 2006-04-13 The Regents Of The University Of Michigan Anticancer compounds and methods
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US7402564B1 (en) 2006-11-10 2008-07-22 Cara Therapeutics, Inc. Synthetic peptide amides
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
CN101622004B (zh) * 2006-12-04 2015-11-25 约翰·霍普金斯大学 酰亚胺化的生物聚合物黏合剂及水凝胶
SG183068A1 (en) * 2007-07-31 2012-08-30 Otsuka Chemical Co Ltd Method for producing peptide
WO2009033659A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Hcv protease inhibitor and octreotide as therapeutic agents
US20100150949A1 (en) * 2008-12-16 2010-06-17 Oncopharmacologics, Inc. Methods and compositions for modulating proline levels
JP6404219B2 (ja) * 2012-09-25 2018-10-10 ジェンザイム・コーポレーション 筋強直性ジストロフィーを治療するためのペプチド結合モルホリノアンチセンスオリゴヌクレオチド
JP6460382B2 (ja) * 2014-11-28 2019-01-30 株式会社豊田自動織機 飽和ヘテロ環含有化合物、並びにこれを用いた二次電池用電極及び二次電池、結着剤、蛍光物質
EP3800192A1 (de) * 2015-03-06 2021-04-07 Stealth Biotherapeutics Corp Verfahren zur herstellung von pharmazeutisch relevanten peptiden
IT202000004528A1 (it) * 2020-03-04 2021-09-04 Carmen Lammi Peptidi auto-assemblanti
CN112262936A (zh) * 2020-10-22 2021-01-26 珠海麦得发生物科技股份有限公司 一种含3-羟基丁酸的饮品及其制备方法和应用
CN115010918B (zh) * 2022-07-21 2023-10-13 中国科学院长春应用化学研究所 一种聚氨基酸及其制备方法、纳米疫苗

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
FR2591227B1 (fr) * 1985-12-06 1988-11-10 Pasteur Institut Peptides capables d'inhiber les interactions entre les virus lav et les lymphocytes t4, produits qui en sont derives et leurs applications
DE3634084A1 (de) * 1986-10-07 1988-04-21 Hanse Chemie Gmbh Modifiziertes reaktionsharz, verfahren zu seiner herstellung und seine verwendung
AU3418389A (en) * 1988-03-28 1989-10-16 Regents Of The University Of California, The Nerve growth factor peptides
JP2625156B2 (ja) * 1988-06-24 1997-07-02 市郎 東 細胞接着活性コア配列の繰り返し構造からなるポリペプチド
EP0406357B1 (de) * 1988-11-09 1998-01-07 Protein Polymer Technologies, Inc. Funktionelles, durch ein rekombinantes verfahren hergestelltes synthetisches proteinpolymer
US5169836A (en) * 1988-11-10 1992-12-08 Trustees Of The University Of Penna. Inhibitors of platelet binding
US5196510A (en) * 1988-12-29 1993-03-23 Cytogen Corporation Molecular recognition units
DK608589D0 (da) * 1989-12-01 1989-12-01 Holm Arne Kemisk fremgangsmaade

Also Published As

Publication number Publication date
EP0503301A3 (en) 1993-06-16
DE69223266T2 (de) 1998-03-19
EP0503301B1 (de) 1997-11-26
DE69223266D1 (de) 1998-01-08
EP0619118A1 (de) 1994-10-12
JPH05186499A (ja) 1993-07-27
EP0619118B1 (de) 1997-06-11
EP0503301A2 (de) 1992-09-16
US5436221A (en) 1995-07-25
DE69220382T2 (de) 1997-09-18
JP2745351B2 (ja) 1998-04-28

Similar Documents

Publication Publication Date Title
DE69220382T2 (de) Verwendung von Peptidderivaten
FI941398A (fi) Modifioituja peptidijohdannaisia
ATE190066T1 (de) Neuartige peptidderivate
DE69431880T2 (de) Verwendung von (2-imidazolin-2-yl-amino) quinoxalinderivaten
ATA53492A (de) Verwendung von ciclosporin zur pulmonalen verabreichung
FR2639947B1 (fr) Derives peptidiques
DE69232476D1 (de) Feststellung von Fehlern
DE706657T1 (de) Wechselwirkungen von inhibierungsproteinen
DK163689D0 (da) Peptidderivater
DE59209936D1 (de) Verwendung von Acetalen
DK375789A (da) Peptidderivater
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
DK132892D0 (da) Proteiner
DK273089A (da) Anvendelse af peptidderivater
DE69514284T2 (de) Herstellung von Catechol-Estrogen-Derivaten
FI941749A (fi) Rekombinantti-Borrelia -proteiinien valmistus
DK301889D0 (da) Peptidderivater
FI934588A (fi) Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben
DE59204051D1 (de) Verwendung von polymodalem beta-Oktogen.
DK177789D0 (da) Peptidderivater
DK657189A (da) Peptidderivater
DE59308823D1 (de) Verwendung von Thioalkandionen als Aromastoffe
DE69218215D1 (de) Entfernung von schwefelwasserstoff
DK171489D0 (da) Peptidderivater
KR930026760U (ko) Tvcr의 개선된 구성

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee